decisionhealth Newsletters, Coder Pink Sheets - 2005 Issue 5 (May)
Competitive acquisition program may have you drug-shopping
Subscribe or sign in to view the full article.
Article Overview
This article explains a proposed CMS competitive acquisition program for physician-administered drugs under Medicare Part B. It is relevant to physicians, particularly ophthalmology practices, and to billing and reimbursement staff following policy changes that could affect drug purchasing, vendor selection, claims handling, and payment workflows. The piece focuses on the general structure of the program, who it would apply to, and the operational changes practices may need to consider.
Why This Topic Matters
The proposal could change how practices obtain, bill for, and manage Medicare Part B drugs, which affects administrative burden, cash flow, and reimbursement processes.
What You Will Learn
- What the proposed competitive acquisition program is intended to change
- Which types of Medicare-covered drugs the proposal would affect
- How the proposed vendor-based purchasing and billing structure would work at a high level
- How the proposal may affect physician practice administration and drug handling
- What timing and participation choices are described in the policy discussion
Who Should Read This
- Physicians
- Ophthalmologists
- Medical coders
- Medical billers
- Practice administrators
- Revenue cycle staff
- Healthcare policy readers
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com